GlassScriptPhysician profile
Jesse David Bane
NPI 1477584837
$2,076.25
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,825 · 2020: $251.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $367.21 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.10 | 2019-2020 | |
| Pfizer INC. | $228.72 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $215.49 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $117.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $112.02 | 2019 | |
| Astellas Pharma US INC | $91.66 | 2019-2020 | |
| Novo Nordisk INC | $90.69 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $76.26 | 2019-2020 | |
| Glaxosmithkline, LLC. | $70.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $68.15 | 2019 | |
| Amarin Pharma, INC. | $67.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $66.97 | 2019 | |
| Boston Scientific Corporation | $50.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $38.72 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.92 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.87 | 2019 | |
| Genzyme Corporation | $19.66 | 2019 | |
| Abbvie INC. | $15.83 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.21 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.25 | 2019 | |
| Lilly USA, LLC | $11.72 | 2019 | |
| Dynavax Technologies Corporation | $10.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Bane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.